BioWorld MedTech

Aug. 11, 2011

Med-tech faces uncertainty in healthcare landscape

ATLANTA — If there was one word that could properly describe the feelings of medical device makers across the U.S., that word would be uncertainty. (Medical Device Daily) Read More

Washington roundup: CMS eyes wider indication for extracorporeal photopheresis

International report: First Latin American use of Medtronic Symplicity performed

New ventures: Misonix now enters surgical wound debridement market

Deals roundup: Despite buyout rejection, Alere acquires more Axis-Shield stock

Financings roundup: Masimo's board authorizes repurchase of up to 3M shares

Agreements/contracts: TrovaGene stops Sequenom, regains transrenal tech rights

Grants roundup: ApoCell awarded $2.9M contract for 12 alpha prototype units

HIT roundup: Boston Sci launches NLI for spinal cord stimulation

Med-Tech Notes

People in the News

Product Briefs

Abbott Vascular gets FDA approval for RX Herculink

MDD's Ortho Extra

Today's news in brief

BioWorld

BioWorld briefs for June 12, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for June 9, 2026

Pre-disease plasma signature may help redefine lung cancer risk

BioWorld

Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...

Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis

BioWorld

Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...

Ethyreal launches to treat the underlying cause of Graves’, TED

BioWorld

Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...